As of 2024-12-13, the Relative Valuation of Global Blood Therapeutics Inc (GBT) is (131.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on Relative Valuation is -292.6%.
The range of the Relative Valuation is (134.48) - (141.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 40.9x | 34.7x |
| Forward P/E multiples | 19.8x - 29.5x | 20.5x |
| Fair Price | (134.48) - (141.17) | (131.90) |
| Upside | -296.3% - -306.1% | -292.6% |
| Date | P/E |